FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366998341> ?p ?o ?g. }

• W4366998341 endingPage "657" @default.
• W4366998341 startingPage "647" @default.
• W4366998341 abstract "Denosumab is an effective antiresorptive molecule and reduces the risk of fracture in postmenopausal osteoporosis. Cessation of denosumab therapy however is associated with rapid declines in bone mineral density (BMD), rises in bone remodeling, and an increased risk of fracture. We evaluated the effect of low dose denosumab (30 mg every 6 months) on the prevention of bone loss following a switch from standard dose (60 mg of denosumab every 6 months) in a prospective observational study.We recruited 114 women 50-90 years of age with postmenopausal osteoporosis at a moderate fracture risk without prior fragility fractures, who had been on denosumab 60 mg every 6 month. These women switched to low dose denosumab 30 mg every 6 months. Mean percentage change in lumbar spine (LS), femoral neck (FN), total hip (TH) and 1/3 distal radius (1/3RAD) BMD at 12 and 24 months were evaluated. Predictors for change in BMD were explored. Subgroup analysis for patients on denosumab 60 mg every 6 months for <3 years and for ≥3 years before switching to low dose denosumab 30 mg was evaluated.At 12 months following a switch from 60 mg to 30 mg of denosumab every 6 months we observed an increase in LS BMD mean percentage change (+2.03%, 95% CI 1.18-2.88, p < 0.001). BMD was stable at the hip and radial sites. Age was found to be a predictor of the mean percentage change in LS BMD for the overall sample. At 24 months, there was a further increase in LS BMD mean percentage change (+3.44%, 95% CI 1.74-5.12, p < 0.001), with stable BMD at other skeletal sites. The 12 month mean BMD percentage change at the LS (p = 0.015), FN (p < 0.001), TH (p < 0.001), and 1/3 RAD (p < 0.001) were found to be predictors of the 24 month mean BMD percentage change. No clinical fractures were reported during 24 months of follow up.We observed stable BMD following a switch from denosumab 60 mg every 6 months to 30 mg every 6 months in this prospective observational study conducted in postmenopausal women at a moderate fracture risk." @default.
• W4366998341 created "2023-04-27" @default.
• W4366998341 creator A5000318626 @default.
• W4366998341 creator A5003988096 @default.
• W4366998341 creator A5007697163 @default.
• W4366998341 creator A5012175838 @default.
• W4366998341 creator A5024440046 @default.
• W4366998341 creator A5031966323 @default.
• W4366998341 creator A5033489648 @default.
• W4366998341 creator A5034789006 @default.
• W4366998341 creator A5038479036 @default.
• W4366998341 creator A5052899916 @default.
• W4366998341 creator A5063080270 @default.
• W4366998341 creator A5064020935 @default.
• W4366998341 creator A5065531405 @default.
• W4366998341 creator A5065954837 @default.
• W4366998341 creator A5072393813 @default.
• W4366998341 creator A5087877468 @default.
• W4366998341 creator A5090142353 @default.
• W4366998341 date "2023-04-25" @default.
• W4366998341 modified "2023-09-26" @default.
• W4366998341 title "Effect of low dose denosumab on bone mineral density in postmenopausal women with osteoporosis after a transition from 60 mg dose: a prospective observational study" @default.
• W4366998341 cites W1957467225 @default.
• W4366998341 cites W1989860636 @default.
• W4366998341 cites W1992637537 @default.
• W4366998341 cites W2005822935 @default.
• W4366998341 cites W2015259527 @default.
• W4366998341 cites W2048346627 @default.
• W4366998341 cites W2058357891 @default.
• W4366998341 cites W2078865928 @default.
• W4366998341 cites W2087574295 @default.
• W4366998341 cites W2122467899 @default.
• W4366998341 cites W2128977360 @default.
• W4366998341 cites W2134910437 @default.
• W4366998341 cites W2160005424 @default.
• W4366998341 cites W2163058169 @default.
• W4366998341 cites W2169251377 @default.
• W4366998341 cites W2397303621 @default.
• W4366998341 cites W2531903877 @default.
• W4366998341 cites W2553653699 @default.
• W4366998341 cites W2594420699 @default.
• W4366998341 cites W2619448414 @default.
• W4366998341 cites W2620350575 @default.
• W4366998341 cites W2743295977 @default.
• W4366998341 cites W2766957057 @default.
• W4366998341 cites W2793425232 @default.
• W4366998341 cites W2902400447 @default.
• W4366998341 cites W2907630950 @default.
• W4366998341 cites W2912223367 @default.
• W4366998341 cites W2912931145 @default.
• W4366998341 cites W2920151790 @default.
• W4366998341 cites W2969420040 @default.
• W4366998341 cites W2985815801 @default.
• W4366998341 cites W3004232792 @default.
• W4366998341 cites W3019606932 @default.
• W4366998341 cites W3030624497 @default.
• W4366998341 cites W3033479596 @default.
• W4366998341 cites W3037523599 @default.
• W4366998341 cites W3046030160 @default.
• W4366998341 cites W3092642176 @default.
• W4366998341 cites W3094494322 @default.
• W4366998341 cites W3116358764 @default.
• W4366998341 cites W3120383256 @default.
• W4366998341 cites W313083427 @default.
• W4366998341 cites W3133129058 @default.
• W4366998341 cites W3145467021 @default.
• W4366998341 cites W3160792603 @default.
• W4366998341 cites W4225996931 @default.
• W4366998341 doi "https://doi.org/10.1007/s12020-022-03230-5" @default.
• W4366998341 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37186270" @default.
• W4366998341 hasPublicationYear "2023" @default.
• W4366998341 type Work @default.
• W4366998341 citedByCount "0" @default.
• W4366998341 crossrefType "journal-article" @default.
• W4366998341 hasAuthorship W4366998341A5000318626 @default.
• W4366998341 hasAuthorship W4366998341A5003988096 @default.
• W4366998341 hasAuthorship W4366998341A5007697163 @default.
• W4366998341 hasAuthorship W4366998341A5012175838 @default.
• W4366998341 hasAuthorship W4366998341A5024440046 @default.
• W4366998341 hasAuthorship W4366998341A5031966323 @default.
• W4366998341 hasAuthorship W4366998341A5033489648 @default.
• W4366998341 hasAuthorship W4366998341A5034789006 @default.
• W4366998341 hasAuthorship W4366998341A5038479036 @default.
• W4366998341 hasAuthorship W4366998341A5052899916 @default.
• W4366998341 hasAuthorship W4366998341A5063080270 @default.
• W4366998341 hasAuthorship W4366998341A5064020935 @default.
• W4366998341 hasAuthorship W4366998341A5065531405 @default.
• W4366998341 hasAuthorship W4366998341A5065954837 @default.
• W4366998341 hasAuthorship W4366998341A5072393813 @default.
• W4366998341 hasAuthorship W4366998341A5087877468 @default.
• W4366998341 hasAuthorship W4366998341A5090142353 @default.
• W4366998341 hasBestOaLocation W43669983411 @default.
• W4366998341 hasConcept C126322002 @default.
• W4366998341 hasConcept C126894567 @default.
• W4366998341 hasConcept C141071460 @default.
• W4366998341 hasConcept C2775854910 @default.
• W4366998341 hasConcept C2776286101 @default.
• W4366998341 hasConcept C2776541429 @default.

• next